316 related articles for article (PubMed ID: 29774475)
1. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
Mariani M; Collins MWG
Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
[TBL] [Abstract][Full Text] [Related]
2. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
[TBL] [Abstract][Full Text] [Related]
3. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients.
Pranckeviciene A; Deltuva VP; Tamasauskas A; Bunevicius A
Clin Neurol Neurosurg; 2017 Dec; 163():18-23. PubMed ID: 29035741
[TBL] [Abstract][Full Text] [Related]
4. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
[TBL] [Abstract][Full Text] [Related]
5. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor.
McCurdy MD; Rane S; Daly BP; Jacobson LA
J Neurooncol; 2016 Mar; 127(1):137-44. PubMed ID: 26725098
[TBL] [Abstract][Full Text] [Related]
6. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
7. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
[TBL] [Abstract][Full Text] [Related]
8. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
10. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
14. Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot.
Meneses K; Benz R; Bail JR; Vo JB; Triebel K; Fazeli P; Frank J; Vance DE
Breast Cancer Res Treat; 2018 Feb; 168(1):259-267. PubMed ID: 29128897
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairments in patients with persistent symptoms attributed to Lyme disease.
Berende A; Agelink van Rentergem J; Evers AWM; Ter Hofstede HJM; Vos FJ; Kullberg BJ; Kessels RPC
BMC Infect Dis; 2019 Oct; 19(1):833. PubMed ID: 31590634
[TBL] [Abstract][Full Text] [Related]
16. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.
Gaynor AM; Ahsan A; Jung D; Schofield E; Li Y; Ryan E; Ahles TA; Root JC
J Cancer Surviv; 2024 Apr; 18(2):466-478. PubMed ID: 35939254
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and functional outcomes of 5-year subarachnoid haemorrhage survivors: comparison to matched healthy controls.
Chahal N; Barker-Collo S; Feigin V
Neuroepidemiology; 2011; 37(1):31-8. PubMed ID: 21757962
[TBL] [Abstract][Full Text] [Related]
18. Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.
Root JC; Andreotti C; Tsu L; Ellmore TM; Ahles TA
J Cancer Surviv; 2016 Jun; 10(3):593-9. PubMed ID: 26658913
[TBL] [Abstract][Full Text] [Related]
19. Pupillary response: cognitive effort for breast cancer survivors.
Myers JS; Kahya M; Mitchell M; Dai J; He J; Moon S; Hamilton K; Valla M; O'Dea A; Klemp J; Kurylo M; Akinwuntan A; Devos H
Support Care Cancer; 2019 Mar; 27(3):1121-1128. PubMed ID: 30097791
[TBL] [Abstract][Full Text] [Related]
20. Anxiety as a Risk Factor for Cognitive Decline: A 12-Year Follow-Up Cohort Study.
Gulpers BJA; Oude Voshaar RC; van Boxtel MPJ; Verhey FRJ; Köhler S
Am J Geriatr Psychiatry; 2019 Jan; 27(1):42-52. PubMed ID: 30409551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
